Showing results (1061-1070 of 2,737) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|January 23, 2020
Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patientsWeifeng Qin, Zhenglin Du, Jingfa Xiao, et al.Pharmacogenomics|December 19, 2019
CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapyFabiana Dalla Vecchia Genvigir, Antony Brayan Campos-Salazar, Claudia Rosso Felipe, et al.Pharmacogenomics|December 19, 2019
Cost-effectiveness of CYP2C19 LOF-guided antiplatelet therapy in Chinese patients with acute coronary syndromeYu Fu, Xin-Yi Zhang, Si-Bei Qin, et al.Pharmacogenomics|December 20, 2019
A potential role for the CDH13/CDH15 gene in repeat revascularization after first percutaneous coronary interventionQian Xiang, Zhiyan Liu, Yun Lu, et al.Pharmacogenomics|December 20, 2019
Impact of CYP2C9, VKORC1, ApoE and ABCB1 polymorphisms on stable warfarin dose requirements in elderly Chinese patientsWenyan Li, Ping Zhao, Liwen Chen, et al.Pharmacogenomics|May 9, 2022
Coriell Life Sciences: empowering the most precise medical care for a healthier worldJeffrey A Shaman, Paul H Chernin, Scott E MegillPharmacogenomics|February 6, 2018
The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variantsAri Allyn-Feuer, Alex Ade, Jasmine A Luzum, et al.Pharmacogenomics|December 7, 2018
Prolonged clonazepam-induced withdrawal symptoms in an NAT2 ultraslow acetylatorTeresa T Ho, Sheeba Varghese Gupta, Amarilis Sanchez-VallePharmacogenomics|June 7, 2022
Pharmacogenomics: a tool to improve medication safety and efficacy in patients with cystic fibrosisColleen M Sakon, Emma M TillmanPharmacogenomics|June 7, 2022
The Festival of Genetics and Personalized MedicineMaria Therianou, Alexandra Gerou, Konstantinos Mitropoulos, et al.Pageof 274